68 related articles for article (PubMed ID: 27544294)
1. In silico construction of HK2-VDAC1 complex and investigating the HK2 binding-induced molecular gating mechanism of VDAC1.
Zhang D; Yip YM; Li L
Mitochondrion; 2016 Sep; 30():222-8. PubMed ID: 27544294
[TBL] [Abstract][Full Text] [Related]
2. Structure-guided simulations illuminate the mechanism of ATP transport through VDAC1.
Choudhary OP; Paz A; Adelman JL; Colletier JP; Abramson J; Grabe M
Nat Struct Mol Biol; 2014 Jul; 21(7):626-32. PubMed ID: 24908397
[TBL] [Abstract][Full Text] [Related]
3. ATP transport through VDAC and the VDAC-tubulin complex probed by equilibrium and nonequilibrium MD simulations.
Noskov SY; Rostovtseva TK; Bezrukov SM
Biochemistry; 2013 Dec; 52(51):9246-56. PubMed ID: 24245503
[TBL] [Abstract][Full Text] [Related]
4. Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder Cancer.
Alhozeel B; Pandey SK; Shteinfer-Kuzmine A; Santhanam M; Shoshan-Barmatz V
Cells; 2024 Apr; 13(7):. PubMed ID: 38607066
[TBL] [Abstract][Full Text] [Related]
5. AMPK/PGC-1α and p53 modulate VDAC1 expression mediated by reduced ATP level and metabolic oxidative stress in neuronal cells.
Wang Z; Xu T; Sun Y; Zhang X; Wang X
Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):162-173. PubMed ID: 38298056
[TBL] [Abstract][Full Text] [Related]
6. HSP90 C-terminal domain inhibition promotes VDAC1 oligomerization via decreasing K274 mono-ubiquitination in Hepatocellular Carcinoma.
Zhang J; Liu L; Li Y; Huang Y; Xiao S; Deng Z; Zheng Z; Li J; Liang M; Xie G; Chen X; Deng Y; Tan W; Su H; Wu G; Cai C; Chen X; Zou F
Neoplasia; 2023 Oct; 44():100935. PubMed ID: 37717471
[TBL] [Abstract][Full Text] [Related]
7. Microglial voltage-dependent anion channel 1 signaling modulates sleep deprivation-induced transition to chronic postsurgical pain.
Wei SN; Zhang H; Lu Y; Yu HJ; Ma T; Wang SN; Yang K; Tian ML; Huang AH; Wang W; Li FS; Li YW
Sleep; 2023 Nov; 46(11):. PubMed ID: 36827092
[TBL] [Abstract][Full Text] [Related]
8. In silico study of the impact of oxidation on pyruvate transmission across the hVDAC1 protein channel.
Rezaei M; Ghasemitarei M; Razzokov J; Yusupov M; Ghorbanalilu M; Ejtehadi MR
Arch Biochem Biophys; 2024 Jan; 751():109835. PubMed ID: 38000492
[TBL] [Abstract][Full Text] [Related]
9. Increase in primary cilia number and length upon VDAC1 depletion contributes to attenuated proliferation of cancer cells.
Dutta A; Halder P; Gayen A; Mukherjee A; Mukherjee C; Majumder S
Exp Cell Res; 2023 Aug; 429(2):113671. PubMed ID: 37276998
[TBL] [Abstract][Full Text] [Related]
10. Abatement of the binding of human hexokinase II enzyme monomers by in-silico method with the design of inhibitory peptides.
Karamifard F; Mazaheri M; Dadbinpour A
In Silico Pharmacol; 2024; 12(1):30. PubMed ID: 38617709
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of VDAC1-derived small molecule peptides increases circulating testosterone levels in male rats.
Martinez-Arguelles DB; Nedow JW; Gukasyan HJ; Papadopoulos V
Front Endocrinol (Lausanne); 2022; 13():1003017. PubMed ID: 36686419
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Effects of Hexokinase 2 Detachment From Mitochondria-Associated Membranes with the Highly Selective Peptide HK2pep.
Ciscato F; Chiara F; Filadi R; Rasola A
Bio Protoc; 2021 Jul; 11(14):e4087. PubMed ID: 34395726
[TBL] [Abstract][Full Text] [Related]
13. Targeting hexokinase 2 for oral cancer therapy: structure-based design and validation of lead compounds.
Chakraborty P; Lubna S; Bhuin S; K D; Chakravarty M; Jamma T; Yogeeswari P
Front Pharmacol; 2024; 15():1346270. PubMed ID: 38529190
[TBL] [Abstract][Full Text] [Related]
14. VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference.
Conti Nibali S; De Siervi S; Luchinat E; Magrì A; Messina A; Brocca L; Mantovani S; Oliviero B; Mondelli MU; De Pinto V; Turato C; Arrigoni C; Lolicato M
iScience; 2024 Jun; 27(6):109853. PubMed ID: 38784007
[TBL] [Abstract][Full Text] [Related]
15. Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma.
Penny HL; Sieow JL; Adriani G; Yeap WH; See Chi Ee P; San Luis B; Lee B; Lee T; Mak SY; Ho YS; Lam KP; Ong CK; Huang RY; Ginhoux F; Rotzschke O; Kamm RD; Wong SC
Oncoimmunology; 2016 Aug; 5(8):e1191731. PubMed ID: 27622062
[TBL] [Abstract][Full Text] [Related]
16. Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma.
Vartanian A; Agnihotri S; Wilson MR; Burrell KE; Tonge PD; Alamsahebpour A; Jalali S; Taccone MS; Mansouri S; Golbourn B; Aldape KD; Zadeh G
Oncotarget; 2016 Oct; 7(43):69518-69535. PubMed ID: 27588472
[TBL] [Abstract][Full Text] [Related]
17. News about VDAC1 in Hypoxia.
Mazure NM
Front Oncol; 2016; 6():193. PubMed ID: 27625993
[TBL] [Abstract][Full Text] [Related]
18. Restoring Pharmacologic Preconditioning in the Aging Heart: Role of Mitophagy/Autophagy.
Ma L; Zhu J; Gao Q; Rebecchi MJ; Wang Q; Liu L
J Gerontol A Biol Sci Med Sci; 2017 Apr; 72(4):489-498. PubMed ID: 27565512
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial tRNA mutations in 2070 Chinese Han subjects with hypertension.
Xue L; Wang M; Li H; Wang H; Jiang F; Hou L; Geng J; Lin Z; Peng Y; Zhou H; Yu H; Jiang P; Mo JQ; Guan MX
Mitochondrion; 2016 Sep; 30():208-21. PubMed ID: 27544295
[TBL] [Abstract][Full Text] [Related]
20. Zinc and p53 disrupt mitochondrial binding of HK2 by phosphorylating VDAC1.
Xue YN; Yu BB; Li JL; Guo R; Zhang LC; Sun LK; Liu YN; Li Y
Exp Cell Res; 2019 Jan; 374(1):249-258. PubMed ID: 30528266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
